GUIZHOU SANLI: Yuexin Pharmaceutical reduced its holdings by 0.1976%

Guizhou Sanli announced that the shareholding reduction plan of its shareholder Hainan Yuexin Pharmaceutical Investment Partnership, which holds more than 5% of the shares, has expired. From July 3, 2025, to October 2, 2025, it will reduce its holdings by 809,900 shares through centralized bidding, accounting for 0.1976% of the company's total share capital; after the reduction, it will hold 20,190,100 shares, accounting for 4.9268%. The previous plan was to reduce no more than 2,049,000 shares, accounting for 0.5000%